Free Trial
NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

Intelligent Bio Solutions logo
$1.65 +0.06 (+3.77%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$1.60 -0.05 (-2.79%)
As of 07:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Key Stats

Today's Range
$1.53
$1.70
50-Day Range
$1.43
$2.25
52-Week Range
$1.10
$3.00
Volume
200,504 shs
Average Volume
122,632 shs
Market Capitalization
$14.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Intelligent Bio Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

INBS MarketRank™: 

Intelligent Bio Solutions scored higher than 8% of companies evaluated by MarketBeat, and ranked 927th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Intelligent Bio Solutions.

  • Earnings Growth

    Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($1.25) to $0.35 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Intelligent Bio Solutions is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Intelligent Bio Solutions is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Intelligent Bio Solutions has a P/B Ratio of 5.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Intelligent Bio Solutions' valuation and earnings.
  • Percentage of Shares Shorted

    7.34% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently increased by 4.79%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Intelligent Bio Solutions does not currently pay a dividend.

  • Dividend Growth

    Intelligent Bio Solutions does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.34% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently increased by 4.79%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Intelligent Bio Solutions has a news sentiment score of 1.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Intelligent Bio Solutions this week, compared to 2 articles on an average week.
  • Search Interest

    5 people have searched for INBS on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.54% of the stock of Intelligent Bio Solutions is held by insiders.

  • Percentage Held by Institutions

    Only 32.97% of the stock of Intelligent Bio Solutions is held by institutions.

  • Read more about Intelligent Bio Solutions' insider trading history.
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INBS Stock News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.tc pixel
See More Headlines

INBS Stock Analysis - Frequently Asked Questions

Intelligent Bio Solutions' stock was trading at $1.40 at the start of the year. Since then, INBS shares have increased by 17.9% and is now trading at $1.65.

Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its quarterly earnings data on Friday, August, 15th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by $0.25. The company earned $0.84 million during the quarter, compared to analyst estimates of $4.30 million. Intelligent Bio Solutions had a negative net margin of 346.22% and a negative trailing twelve-month return on equity of 231.13%.

Shares of Intelligent Bio Solutions reverse split on the morning of Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include SoFi Technologies (SOFI), Plug Power (PLUG), Allarity Therapeutics (ALLR), Adial Pharmaceuticals (ADIL), AMC Entertainment (AMC), ARMOUR Residential REIT (ARR) and BIOLASE (BIOL).

Company Calendar

Last Earnings
8/15/2025
Today
8/29/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:INBS
CIK
1725430
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.57 million
Net Margins
-346.22%
Pretax Margin
-347.36%
Return on Equity
-231.13%
Return on Assets
-108.24%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.77
Quick Ratio
0.65

Sales & Book Value

Annual Sales
$3.05 million
Price / Sales
4.86
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.31 per share
Price / Book
5.32

Miscellaneous

Outstanding Shares
8,980,000
Free Float
8,841,000
Market Cap
$14.82 million
Optionable
Not Optionable
Beta
4.59
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:INBS) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners